ArticleHaematologica2020
A novel, highly potent and selective phosphodiesterase-9 inhibitor for the treatment of sickle cell disease.
James G McArthur et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
27 papers cite it
this papertrialcites it